Franziska Willis1, Martin Schneider2. 1. Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland. 2. Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland. martin.schneider@med.uni-heidelberg.de.
Abstract
BACKGROUND: Retroperitoneal soft tissue sarcomas are rare and heterogeneous tumors with high recurrence rates that require a multimodal treatment approach and a surgical resection strategy adapted to tumor localization and histological subtype. OBJECTIVE: Based on current scientific data this article intends to provide an overview on subtype-specific features, prognostic factors and operative techniques in the surgical management of retroperitoneal soft tissue sarcomas. MATERIAL AND METHODS: A review of the literature addressing surgical management of retroperitoneal soft tissue sarcomas was performed. Current evidence and recommendations were summarized. RESULTS AND CONCLUSION: Macroscopically complete tumor resection represents the sole curative treatment option for both primary and recurrent retroperitoneal soft tissue sarcomas. To minimize the probability of tumor-infiltrated resection margins, compartmental resection has become a standard treatment for retroperitoneal soft tissue sarcomas. This approach includes resection of all organs and structures adjacent to the tumor. Multivisceral resection is often associated with this approach and it is acceptable in terms of morbidity and mortality if performed at a center with experience in retroperitoneal sarcoma surgery. Histologic subtype, tumor grading, and quality of initial surgical treatment are major prognostic factors for oncologic overall survival.
BACKGROUND: Retroperitoneal soft tissue sarcomas are rare and heterogeneous tumors with high recurrence rates that require a multimodal treatment approach and a surgical resection strategy adapted to tumor localization and histological subtype. OBJECTIVE: Based on current scientific data this article intends to provide an overview on subtype-specific features, prognostic factors and operative techniques in the surgical management of retroperitoneal soft tissue sarcomas. MATERIAL AND METHODS: A review of the literature addressing surgical management of retroperitoneal soft tissue sarcomas was performed. Current evidence and recommendations were summarized. RESULTS AND CONCLUSION: Macroscopically complete tumor resection represents the sole curative treatment option for both primary and recurrent retroperitoneal soft tissue sarcomas. To minimize the probability of tumor-infiltrated resection margins, compartmental resection has become a standard treatment for retroperitoneal soft tissue sarcomas. This approach includes resection of all organs and structures adjacent to the tumor. Multivisceral resection is often associated with this approach and it is acceptable in terms of morbidity and mortality if performed at a center with experience in retroperitoneal sarcoma surgery. Histologic subtype, tumor grading, and quality of initial surgical treatment are major prognostic factors for oncologic overall survival.
Authors: Syvie Bonvalot; Chandrajit P Raut; Raphael E Pollock; Piotr Rutkowski; Dirk C Strauss; Andrew J Hayes; Frits Van Coevorden; Marco Fiore; Eberhard Stoeckle; Peter Hohenberger; Alessandro Gronchi Journal: Ann Surg Oncol Date: 2012-04-03 Impact factor: 5.344
Authors: Dario Callegaro; Chandrajit P Raut; Deanna Ng; Dirk C Strauss; Charles Honoré; Eberhard Stoeckle; Sylvie Bonvalot; Rick L Haas; Nikolaos Vassos; Lorenzo Conti; Rebecca A Gladdy; Mark Fairweather; Winan van Houdt; Yvonne Schrage; Frits van Coevorden; Piotr Rutkowski; Rosalba Miceli; Alessandro Gronchi; Carol J Swallow Journal: Ann Surg Oncol Date: 2020-10-18 Impact factor: 5.344
Authors: Sylvie Bonvalot; Alessandro Gronchi; Cécile Le Péchoux; Carol J Swallow; Dirk Strauss; Pierre Meeus; Frits van Coevorden; Stephan Stoldt; Eberhard Stoeckle; Piotr Rutkowski; Marco Rastrelli; Chandrajit P Raut; Daphne Hompes; Antonino De Paoli; Claudia Sangalli; Charles Honoré; Peter Chung; Aisha Miah; Jean Yves Blay; Marco Fiore; Jean-Jacques Stelmes; Angelo P Dei Tos; Elizabeth H Baldini; Saskia Litière; Sandrine Marreaud; Hans Gelderblom; Rick L Haas Journal: Lancet Oncol Date: 2020-09-14 Impact factor: 41.316
Authors: Ferdinando Carlo Maria Cananzi; Laura Ruspi; Marco Fiore; Federico Sicoli; Vittorio Quagliuolo; Alessandro Gronchi Journal: Surgery Date: 2021-03-31 Impact factor: 3.982
Authors: Th van Dalen; J M Plooij; F van Coevorden; A N van Geel; H J Hoekstra; Ch Albus-Lutter; P J Slootweg; A Hennipman Journal: Eur J Surg Oncol Date: 2006-10-31 Impact factor: 4.424
Authors: Daniel A Anaya; Guy Lahat; Jun Liu; Yan Xing; Janice N Cormier; Peter W Pisters; Dina C Lev; Raphael E Pollock Journal: Ann Surg Date: 2009-01 Impact factor: 12.969